Letter by Liu et al Regarding Article, "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)"
Circulation
.
2025 Sep 9;152(10):e92-e93.
doi: 10.1161/CIRCULATIONAHA.125.074708.
Epub 2025 Sep 8.
Authors
Guoqing Liu
#
1
,
Chuwen Fu
#
1
,
Jian Xie
1
Affiliation
1
Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
#
Contributed equally.
PMID:
40920838
DOI:
10.1161/CIRCULATIONAHA.125.074708
No abstract available
Publication types
Letter